NuGen Medical Devices Inc. announced the appointment of Greg Gironda to the Company's Advisory Board. Greg Gironda has over 30 years of pharmaceutical and biotechnology experience. Currently, Greg is the managing partner of Pharmacense, a company that provides corporate development and strategic planning services for life science companies.

Prior to Pharmacense, Greg held various strategic planning and business development roles at companies like King Pharmaceuticals, Labopharm, EMD Serono, Neura Therapeutik, and Genentech. While at Serono (EMD Serono), Greg was the first to launch a combination needle-free device, cool.click and a biologic, Saizen recombinant growth hormone. To support this combination, Greg established a team of reimbursement specialists called Connections for Growth, the GHMonitor, a clinical registry for patients on Saizen and cool.click and the Nurse Network, a team of nurses throughout the U.S. that trained both pediatric endocrinology nurses and Saizen patients.

He also developed extensive training materials on the use of the cool.click needle-free device and a direct-to-patient campaign.